AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21482925 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 19735398 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 30 microg x kg(‐1) with cotton blanket
Number of subjects: 120
Study 19735398 — intervention group
Group type: COMPARATOR
Intervention: Forced-air warmer
Number of subjects: 120
Study 19735398 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-air warmer with midazolam 30 microg x kg(‐1)
Number of subjects: 120
Study 19735398 — intervention group
Group type: COMPARATOR
Intervention: Cotton blanket with saline injection
Number of subjects: 120
Study 17722829 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment for 60-90 sessions after rehabilitation training
Number of subjects: 40
Study 17722829 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation training including ABA training, Conductive Education Approach, and sensory integration training for about 90 sessions
Number of subjects: 40
Study 17722829 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 40
Study 17722829 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation training
Number of subjects: 40
Study 15161075 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal vaccination with cholera toxin B subunit
Number of subjects: 0
Study 15161075 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal vaccination with cholera toxin B subunit
Number of subjects: 0
Study 15161075 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrajejunal vaccination with cholera toxin B subunit
Number of subjects: 0
Study 15161075 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vaccination with cholera toxin B subunit
Number of subjects: 0
Study 11484451 — intervention group
Group type: EXPERIMENTAL
Intervention: Josamycin 50 mg.kg‐1.day‐1 b.i.d for 5 days
Number of subjects: 325
Study 11484451 — intervention group
Group type: COMPARATOR
Intervention: Penicillin 50,000 to 100,000 IU/day t.i.d for 10 days
Number of subjects: 325
Study 9656557 — intervention group
Group type: EXPERIMENTAL
Intervention: Single nightly prophylactic dose of an antibiotic
Number of subjects: 150
Study 9656557 — intervention group
Group type: EXPERIMENTAL
Intervention: Single nightly dose of oxybutinin (or divided in 2-4 doses)
Number of subjects: 150
Study 9656557 — intervention group
Group type: EXPERIMENTAL
Intervention: Single nightly prophylactic dose of an antibiotic and oxybutinin as in group II
Number of subjects: 150
Study 7914462 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive bilateral electroconvulsive therapy (ECT)
Number of subjects: 35
Study 2494016 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambient temperature of 33 degrees C
Number of subjects: 6
Study 2494016 — intervention group
Group type: COMPARATOR
Intervention: Ambient temperature of 23 degrees C
Number of subjects: 6
Study 4457275 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium picosulphate
Number of subjects: 50
Study 4457275 — intervention group
Group type: COMPARATOR
Intervention: Standardised senna
Number of subjects: 50
Study 31475497 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 90
Study 31475497 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuyang-pot warming
Number of subjects: 90
Study 31475497 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Fuyang-pot warming and EA
Number of subjects: 90
Study 29074352 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA): bolus of 10mg/kg at induction followed by infusion of 1mg/kg/h intraoperatively and for 24h postoperatively
Number of subjects: 131
Study 29074352 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 131
Study 26055226 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom-made hydrogel silicone contact lens (Kerasoft-IC CL)
Number of subjects: 30
Study 26055226 — intervention group
Group type: COMPARATOR
Intervention: Sector management control (SMC) designs
Number of subjects: 30
Study 23878021 — intervention group
Group type: EXPERIMENTAL
Intervention: Intended harms
Number of subjects: 0
Study 23878021 — intervention group
Group type: COMPARATOR
Intervention: Unintended harms
Number of subjects: 0
Study 21668442 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid therapy
Number of subjects: 77
Study 21668442 — intervention group
Group type: EXPERIMENTAL
Intervention: Age at onset of spasms
Number of subjects: 77
Study 21668442 — intervention group
Group type: EXPERIMENTAL
Intervention: Lead time to treatment
Number of subjects: 77
Study 19504550 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency surgery of the soft palate
Number of subjects: 32
Study 19504550 — intervention group
Group type: COMPARATOR
Intervention: Placebo (insertion of applicator without energy delivery)
Number of subjects: 32
Study 16307711 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent task of randomly generating months of the year aloud (dual-task condition)
Number of subjects: 42
Study 16307711 — intervention group
Group type: EXPERIMENTAL
Intervention: Articulatory suppression by repeating the word 'December' (dual-task condition)
Number of subjects: 42
Study 16307711 — intervention group
Group type: COMPARATOR
Intervention: Single-task condition (baseline)
Number of subjects: 42
Study 12727575 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of a third heart sound (S(3))
Number of subjects: 4102
Study 12727575 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated jugular venous pressure
Number of subjects: 4102
Study 12727575 — intervention group
Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 4102
Study 12727575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4102
Study 11256058 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients identified as distressed by GP
Number of subjects: 0
Study 11256058 — intervention group
Group type: COMPARATOR
Intervention: Patients identified as not distressed by GP
Number of subjects: 0
Study 11256058 — intervention group
Group type: EXPERIMENTAL
Intervention: Distressed patients not recognized as such
Number of subjects: 0
Study 11256058 — intervention group
Group type: EXPERIMENTAL
Intervention: Personality measures (emotional dependency and health locus of control)
Number of subjects: 0
Study 9257429 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (ACT: 5‐fluorouracil and levamisole)
Number of subjects: 95
Study 9257429 — intervention group
Group type: COMPARATOR
Intervention: Follow-up after radical surgery (Control)
Number of subjects: 95
Study 9257429 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (ACT)
Number of subjects: 95
Study 8224687 — intervention group
Group type: EXPERIMENTAL
Intervention: Main pancreatic duct stent
Number of subjects: 98
Study 8224687 — intervention group
Group type: COMPARATOR
Intervention: No stent
Number of subjects: 98
Study 3948545 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (7.2 mg/kg)
Number of subjects: 9
Study 3948545 — intervention group
Group type: COMPARATOR
Intervention: Aminophylline (200 mg)
Number of subjects: 9
Study 3948545 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (various doses: 0.2, 2.5, 5.6, 7.2 mg/kg)
Number of subjects: 9
Study 31607352 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong exercise (5-week intervention in RCT1)
Number of subjects: 287
Study 31607352 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong exercise (8-week intervention in RCT2)
Number of subjects: 287
Study 28001492 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal temporal framing
Number of subjects: 262
Study 28001492 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal temporal framing
Number of subjects: 262
Study 28001492 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal temporal framing (Amazon Mechanical Turk data)
Number of subjects: 262
Study 28001492 — intervention group
Group type: COMPARATOR
Intervention: No messages
Number of subjects: 262
Study 26354054 — intervention group
Group type: EXPERIMENTAL
Intervention: Udenafil and aceclofenac
Number of subjects: 216
Study 26354054 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study 23724570 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 43
Study 23724570 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 43
Study 21422367 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (LNF) with surgeon experience >30 LNFs (LNFII)
Number of subjects: 288
Study 21422367 — intervention group
Group type: COMPARATOR
Intervention: Conventional Nissen fundoplication (CNF)
Number of subjects: 288
Study 21422367 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Nissen fundoplication (LNF) with surgeon experience >5 LNFs (LNFI)
Number of subjects: 288
Study 18840257 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen (0, 40, and 80 mg)
Number of subjects: 18
Study 18840257 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen alone
Number of subjects: 18
Study 18840257 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen in combination with alcohol
Number of subjects: 18
Study 18840257 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 18
Study 18840257 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 16505224 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (8 mg for 4 months)
Number of subjects: 46
Study 16505224 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 16505224 — intervention group
Group type: COMPARATOR
Intervention: Nondiabetic plaques
Number of subjects: 46
Study 15291903 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment group (acupuncture and Chinese herbal medicine)
Number of subjects: 52
Study 15291903 — intervention group
Group type: COMPARATOR
Intervention: Control group (acupuncture applied to non-acupuncture points and non-specific Chinese herbal formula)
Number of subjects: 52
Study 11815726 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.625 mg conjugated equine estrogen (CEE) and 2.5 mg medroxyprogesterone acetate (MPA) every other day
Number of subjects: 68
Study 11815726 — intervention group
Group type: COMPARATOR
Intervention: 0.625 mg CEE and 2.5 mg MPA every day
Number of subjects: 68
Study 11815726 — intervention group
Group type: EXPERIMENTAL
Intervention: Low estradiol group (<15 pg/ml)
Number of subjects: 68
Study 11815726 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle estradiol group (>=15 and <25 pg/ml)
Number of subjects: 68
Study 11815726 — intervention group
Group type: EXPERIMENTAL
Intervention: High estradiol group (>=25 pg/ml)
Number of subjects: 68
Study 11815726 — intervention group
Group type: EXPERIMENTAL
Intervention: Low estradiol group
Number of subjects: 68
Study 9403204 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (Sandoglobulin) at a dose of 1 g/kg before surgery
Number of subjects: 60
Study 9403204 — intervention group
Group type: COMPARATOR
Intervention: Control group (no immunoglobulin treatment)
Number of subjects: 60
Study 8435693 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug treatment (primarily antidepressants)
Number of subjects: 181
Study 8435693 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive and behaviour therapy
Number of subjects: 181
Study 8435693 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help treatment programme
Number of subjects: 181
Study 8435693 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 181
Study 3308992 — intervention group
Group type: EXPERIMENTAL
Intervention: Benson's Relaxation Technique (BRT)
Number of subjects: 40
Study 3308992 — intervention group
Group type: COMPARATOR
Intervention: Attention-distraction control group (CA)
Number of subjects: 40
Study 3308992 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmic breathing exercise (RB)
Number of subjects: 40
Study 3308992 — intervention group
Group type: COMPARATOR
Intervention: Standard control (CB)
Number of subjects: 40
Study 29764000 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic clowning and video activities
Number of subjects: 195
Study 29764000 — intervention group
Group type: COMPARATOR
Intervention: Control group (no therapeutic clowning)
Number of subjects: 195
Study 27382098 — intervention group
Group type: EXPERIMENTAL
Intervention: ECF plus cetuximab
Number of subjects: 245
Study 27382098 — intervention group
Group type: EXPERIMENTAL
Intervention: IC plus cetuximab
Number of subjects: 245
Study 27382098 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFOX plus cetuximab
Number of subjects: 245
Study 24464746 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma galectin 3 (Gal‐3) measured using ELISA
Number of subjects: 924
Study 24464746 — intervention group
Group type: COMPARATOR
Intervention: Control group (subjects alive and free of HF at the time of index case occurrence)
Number of subjects: 924
Study 22210571 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 146
Study 22210571 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 146
Study 20608035 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of lascropuncture infrared radiation and manual therapy
Number of subjects: 120
Study 20608035 — intervention group
Group type: COMPARATOR
Intervention: Traditional treatment
Number of subjects: 120
Study 18684311 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose KRG (9 g/day)
Number of subjects: 61
Study 18684311 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose KRG (4.5 g/day)
Number of subjects: 61
Study 18684311 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 61
Study 16401158 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 85
Study 16401158 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 85
Study 11503980 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous repair
Number of subjects: 66
Study 11503980 — intervention group
Group type: COMPARATOR
Intervention: Open repair
Number of subjects: 66
Study 9763721 — intervention group
Group type: EXPERIMENTAL
Intervention: AD + mefloquine
Number of subjects: 380
Study 9763721 — intervention group
Group type: COMPARATOR
Intervention: AD + placebo
Number of subjects: 380
Study 7918926 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg/day
Number of subjects: 12
Study 7918926 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg/day
Number of subjects: 12
Study 7918926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 29120040 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostin 15M (15(S)15 methyl PGF2alpha) at a dose of 250 microg
Number of subjects: 0
Study 29120040 — intervention group
Group type: COMPARATOR
Intervention: Control group (no drugs for cervical dilatation)
Number of subjects: 0
Study 29120040 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostin 15M
Number of subjects: 0
Study 31687984 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic resistance exercise training for 12 weeks
Number of subjects: 60
Study 29896793 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient medical services within 7 days postdischarge
Number of subjects: 497
Study 29896793 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory services within 7 days postdischarge
Number of subjects: 497
Study 28371338 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g freeze‐dried nasturtium leaf material
Number of subjects: 15
Study 28371338 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 15
Study 23571143 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic ultrasound (LUS)
Number of subjects: 253
Study 23571143 — intervention group
Group type: COMPARATOR
Intervention: Transabdominal ultrasound (TAU)
Number of subjects: 253
Study 21735688 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal 17beta-estradiol (Oesclim 50) combined with oral norethisterone 2.5 mg daily (Primolut-Nor)
Number of subjects: 39
Study 21735688 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral 2 mg 17beta-estradiol combined with oral 1 mg daily norethisterone (Kliogest)
Number of subjects: 39
Study 21735688 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control Group C)
Number of subjects: 39
Study 19884716 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF+ADM+EMD
Number of subjects: 15
Study 19884716 — intervention group
Group type: COMPARATOR
Intervention: CAF+ADM
Number of subjects: 15
Study 16720445 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS) 200 microg once daily (QD)
Number of subjects: 298
Study 16720445 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 298
Study 16720445 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS) 200 microg QD
Number of subjects: 298
Study 15176158 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelaic acid 15% gel
Number of subjects: 0
Study 15176158 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense pulsed light therapy
Number of subjects: 0
Study 15176158 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose doxycycline hyclate
Number of subjects: 0
Study 15176158 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide/clindamycin gel
Number of subjects: 0
Study 15176158 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment
Number of subjects: 0
Study 15176158 — intervention group
Group type: EXPERIMENTAL
Intervention: New formulations of metronidazole and sulfacetamide 10%/sulfur 5%
Number of subjects: 0
Study 11753747 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective Serotonin Reuptake Inhibitors (SSRIs)
Number of subjects: 0
Study 11753747 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychostimulants
Number of subjects: 0
Study 11753747 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional tricyclic antidepressants
Number of subjects: 0
Study 11753747 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 9274080 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant-retained mandibular overdentures
Number of subjects: 90
Study 9274080 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatments
Number of subjects: 90
Study 9274080 — intervention group
Group type: COMPARATOR
Intervention: All treatment modalities
Number of subjects: 90
Study 8175848 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal femoral prosthesis without cement (group 1)
Number of subjects: 4
Study 8175848 — intervention group
Group type: COMPARATOR
Intervention: Proximal femoral prosthesis with cement (group 2)
Number of subjects: 4
Study 8175848 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified femoral prosthesis without hydroxyapatite coating (group 3)
Number of subjects: 4
Study 8175848 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified femoral prosthesis with hydroxyapatite coating (group 4)
Number of subjects: 4
Study 8175848 — intervention group
Group type: EXPERIMENTAL
Intervention: Migration test applied to all groups
Number of subjects: 4
Study 3052169 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentazocine
Number of subjects: 82
Study 3052169 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 82
Study 3052169 — intervention group
Group type: COMPARATOR
Intervention: Both drugs
Number of subjects: 82
Study 31965406 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Outcomes Study Sleep Questionnaire (MOSSQ)
Number of subjects: 7604
Study 31222540 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg methylprednisolone intravenously on the induction of anaesthesia
Number of subjects: 60
Study 28497569 — intervention group
Group type: EXPERIMENTAL
Intervention: AVP-825 (22 mg sumatriptan nasal powder)
Number of subjects: 185
Study 28497569 — intervention group
Group type: COMPARATOR
Intervention: Oral Sumatriptan (100 mg)
Number of subjects: 185
Study 25567657 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine 10 mg orally for 8 days + Ondansetron 8 mg intravenously 30 min before chemotherapy
Number of subjects: 84
Study 25567657 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron 8 mg intravenously 30 min before chemotherapy
Number of subjects: 84
Study 23374650 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable polymer biolimus-eluting stent (Nobori, Terumo, Tokyo, Japan)
Number of subjects: 2707
Study 23374650 — intervention group
Group type: COMPARATOR
Intervention: Durable polymer everolimus-eluting stent (Xience V or Prime, Abbott Vascular, Santa Clara, CA, USA, or Promus, Boston Scientific, Natick, MA, USA)
Number of subjects: 2707
Study 22005587 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT plus low-energy-density diet (CBT+ED)
Number of subjects: 50
Study 22005587 — intervention group
Group type: COMPARATOR
Intervention: CBT plus General Nutrition counseling (CBT+GN)
Number of subjects: 50
Study 19480091 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir added to an optimised antiretroviral regimen
Number of subjects: 40
Study 19480091 — intervention group
Group type: COMPARATOR
Intervention: Optimised regimen plus placebo
Number of subjects: 40
Study 19480091 — intervention group
Group type: EXPERIMENTAL
Intervention: Raltegravir/tenofovir/lamivudine
Number of subjects: 40
Study 19480091 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz/tenofovir/lamivudine
Number of subjects: 40
Study 22422607 — intervention group
Group type: EXPERIMENTAL
Intervention: DEB plus BMS
Number of subjects: 117
Study 22422607 — intervention group
Group type: COMPARATOR
Intervention: BMS
Number of subjects: 117
Study 22422607 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel DES
Number of subjects: 117
Study 15981145 — intervention group
Group type: EXPERIMENTAL
Intervention: Teaching intervention (specific teaching technique not detailed)
Number of subjects: 36
Study 12859101 — intervention group
Group type: COMPARATOR
Intervention: Starting on the first day of the period (n = 80)
Number of subjects: 160
Study 12859101 — intervention group
Group type: EXPERIMENTAL
Intervention: Starting on the seventh day of the period (n = 80)
Number of subjects: 160
Study 9855810 — intervention group
Group type: EXPERIMENTAL
Intervention: New teaching aid for charting methods
Number of subjects: 58
Study 9855810 — intervention group
Group type: COMPARATOR
Intervention: Traditional teaching method
Number of subjects: 58